EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Management of Intermediate- to High-Risk Pulmonary Embolism During Pregnancy: A Three-Case Series

Zohre Naderi, Maryam Movahedi, Parvin Bahrami

Clinical Medicine Insights: Case Reports · 2026-07 · 19

DOI: 10.1177/11795476261485719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Insights: Case Reports, online erschienen am 16.11.2026. Verfasst von Zohre Naderi und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary embolism (PE) remains a major cause of maternal morbidity and mortality during pregnancy, and management of intermediate- to high-risk PE remains particularly challenging due to the limited evidence regarding thrombolytic therapy in this population. We report three cases of pregnancy-associated intermediate-risk PE managed at a tertiary referral center between 2020 and 2024. All patients had imaging-confirmed PE with right ventricular (RV) dysfunction and elevated cardiac biomarkers. A 31-year-old woman at 11 weeks’ gestation initially improved with anticoagulation but subsequently developed sudden cardiac arrest and underwent rescue systemic thrombolysis during cardiopulmonary resuscitation without successful recovery. A 38-year-old woman with underlying gastrointestinal stromal tumor was managed conservatively with anticoagulation alone because of high bleeding risk and had favorable maternal and fetal outcomes. A third patient at 13 weeks’ gestation demonstrated persistent hypoxemia, tachycardia, and RV dysfunction despite anticoagulation and was successfully treated with low-dose alteplase (50 mg), resulting in marked clinical and echocardiographic improvement without maternal or fetal complications. These cases highlight the complexity of therapeutic decision-making in pregnant women with intermediate-risk PE. In selected patients with persistent right ventricular dysfunction or clinical deterioration despite anticoagulation, reduced-dose systemic thrombolysis may be considered as an individualized therapeutic strategy within a multidisciplinary management framework.

Zitieren

APA

Naderi, Z., Movahedi, M., & Bahrami, P. (2026). Management of Intermediate- to High-Risk Pulmonary Embolism During Pregnancy: A Three-Case Series. Clinical Medicine Insights: Case Reports, 19. https://doi.org/10.1177/11795476261485719

Vancouver

Naderi Z, Movahedi M, Bahrami P. Management of Intermediate- to High-Risk Pulmonary Embolism During Pregnancy: A Three-Case Series. Clinical Medicine Insights: Case Reports. 2026;19. doi:10.1177/11795476261485719

BibTeX
@article{Naderi2026,
  author = {Naderi, Zohre and Movahedi, Maryam and Bahrami, Parvin},
  title = {Management of Intermediate- to High-Risk Pulmonary Embolism During Pregnancy: A Three-Case Series},
  journal = {Clinical Medicine Insights: Case Reports},
  year = {2026},
  volume = {19},
  doi = {10.1177/11795476261485719}
}
Kostenlos starten →